Axa’s Inspire Medical Systems INSP Stock Holding History

Axa’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,109	Closed	-$1.83M	–	564
2025 Q2	$1.83M	Buy	+14,109	New	+$2.05M	0.01%	788

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axa's INSP Position: Q3 2025 in Review

Axa sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 14,109 shares — an estimated $1.83M sold.

Axa first reported a position in INSP in Q2 2025 and held it in 1 quarter. The position peaked at $1.83M in Q2 2025. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

Axa reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
Axa sold 14,109 Inspire Medical Systems shares in Q3 2025, an estimated $1.83M.
Axa first reported a position in Inspire Medical Systems in Q2 2025 and held it in 1 quarter.
Axa's Inspire Medical Systems position peaked at $1.83M in Q2 2025.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.